Ad
related to: drugs, brain development
Search results
Menopause treatments can help with hot flashes and other symptoms – but many people aren’t aware of...
The Conversation via Yahoo News· 22 hours agoThe number of patients prescribed hormonal therapy plummeted after 2002, due to findings experts...
Prenatal supplements fall woefully short in providing crucial nutrition during pregnancy – and most...
San Francisco Chronicle· 4 days agoThere are no rules that require these supplements to contain any nutrients at all, let alone the appropriate doses. Not surprisingly, research shows that none of the most widely available over-the-counter ...
Neurolixis expands rare autism disorders research program
Digital Journal· 4 days agoNeurolixis, Inc., a biopharmaceutical company that discovers and develops novel treatments to treat disorders of the brain, today announced that the United States Patent and ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 SUZHOU, China ...
Boca Raton company wins Lockheed Martin contract - South Florida Business Journal
The Business Journals· 6 days agoTerran Orbital (NYSE: LLAP) will build 18 satellite buses for Lockheed Martin’s Space Development Agency Tranche 2 Tracking Layer contract. Aerospace and defense giant Lockheed ...
Rapport Therapeutics raises up to $154 million in IPO - Boston Business Journal
The Business Journals· 1 day agoRapport Therapeutics Inc. said late Thursday it has raised $154 million in an initial public offering. Rapport (Nasdaq: RAPP), a Boston-based maker of small-molecule medicines for patients with ...
'Transformative': Novel Drug for Narcolepsy Effective in Mid-Stage Trial
MedPage Today· 3 days agoUnlike its predecessor, TAK-861 did not result in any hepatotoxicity or serious adverse events
The future of drug testing: Vascularized organ-on-a-chip technologies
Medical Xpress· 5 days agoResearchers from Shanghai University and the University of California Los Angeles have made significant strides in the field of in vitro vascularized organ-on-a-chip systems, offering a promising ...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 4 days agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung cancer (NSCLC).
Goldman Sachs raises Royalty Pharma stock target on deal activity By Investing.com
Investing.com· 23 hours agoThe adjustment reflects the latest revenue and future projections for active royalty deals following...